High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: Hematopoietic tolerance and efficacy

M. DeMagalhaes-Silverman, L. Hammert, B. Lembersky, J. Lister, W. Rybka, E. Ball

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: Hematopoietic tolerance and efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences